Benzenes

<p>2-Bromo-5-hydroxybenzoic acid methyl ester (2BB) is a phenoxy activator that activates the glucokinase activator. It has been shown to have a glucose lowering effect in both animal and human studies. 2BB is orally bioavailable and has an allosteric mode of action, which means it works by binding to the allosteric site on the enzyme's active site, thereby increasing its activity. It binds to the benzamide of glucokinase, which causes an increase in glucose uptake and utilization by cells. 2BB is being studied for use as an oral treatment for type II diabetes mellitus.</p>

<p>2-fluoro-4-iodobenzonitrile is a potent inhibitor of the functions of VEGFR receptors. It inhibits the proliferation and migration of cancer cells by binding to VEGFR receptors, which are tyrosine kinases that regulate cell growth and differentiation. 2-Fluoro-4-iodobenzonitrile has been shown to inhibit angiogenesis, or the formation of new blood vessels, in vitro. This drug also has potent inhibitory activity against tumor growth in vivo. Clinical trials have shown that 2-fluoro-4-iodobenzonitrile can be used to treat various types of cancers, including breast cancer and colon cancer.</p>